The gastrointestinal tolerability of a novel COX-2 selective inhibitor, lumiracoxib, in osteoarthritis patients: Pooled analysis

被引：1
|
作者：
Hawkey, CJ
Gitton, X
Gimona, A
Hoexter, G
Weinstein, WM
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)82591-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A512 / A512
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND TOLERABILITY OF LUMIRACOXIB IN PATIENTS WITH OSTEOARTHRITIS: A POOLED ANALYSIS
    Fleischmann, R.
    Berenbaum, F.
    Sloan, V.
    Moore, A.
    Couturier, A.
    RHEUMATOLOGY, 2004, 43 : 65 - 65
  • [2] Lumiracoxib (Prexige®):: a new selective cox-2 inhibitor
    Mysler, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (06) : 606 - 611
  • [3] Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
    Watson, DJ
    Harper, SE
    Zhao, PL
    Quan, H
    Bolognese, JA
    Simon, TJ
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) : 2998 - 3003
  • [4] Lumiracoxib: More than just a selective COX-2 inhibitor
    Castanda-Hernandez, Gilberto
    Ortiz, Mario
    Granados-Soto, Vinicio
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 84 - 84
  • [5] Lumiracoxib.: Antiarthritic, COX-2 inhibitor
    Sorbera, LA
    Castañer, J
    Bayés, M
    Silvestre, JS
    DRUGS OF THE FUTURE, 2002, 27 (08) : 740 - 747
  • [6] Comparison of the gastrointestinal tolerability of Celocoxib, a selective COX-2 inhibitor and indomethacin in the experimental rat
    Tibble, JA
    Sigthorrson, G
    Bjarnason, I
    GUT, 2000, 46 : A50 - A50
  • [7] Gastrointestinal tolerability of lumiracoxib in patients with osteoarthritis and rheumatoid arthritis
    Hawkey, CJ
    Gitton, X
    Hoexter, G
    Richard, D
    Weinstein, WM
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (01) : 57 - 66
  • [8] Determinants for the selective inhibition of COX-2 by lumiracoxib
    Blobaum, Anna L.
    Marnett, Lawrence J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 121 - 122
  • [9] Gastrointestinal toxicity and tolerability of COX-2 selective inhibitors: A metaanalysis
    McGrath, J
    Sy, R
    Gregor, J
    GASTROENTEROLOGY, 2004, 126 (04) : A616 - A616
  • [10] Lumiracoxib is a selective inhibitor of cyclooxygenase-2 in patients with osteoarthritis
    Patrignani, P
    Campestrini, J
    Branson, J
    Girani, M
    Hartmann, S
    Rordorf, C
    Patrono, C
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 368 - 368
12345